rs149979955

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS1

The NM_006030.4(CACNA2D2):​c.284G>A​(p.Arg95His) variant causes a missense change. The variant allele was found at a frequency of 0.000178 in 1,599,126 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00018 ( 0 hom. )

Consequence

CACNA2D2
NM_006030.4 missense

Scores

1
5
12

Clinical Significance

Likely benign criteria provided, single submitter B:2

Conservation

PhyloP100: 4.26

Publications

2 publications found
Variant links:
Genes affected
CACNA2D2 (HGNC:1400): (calcium voltage-gated channel auxiliary subunit alpha2delta 2) Calcium channels mediate the entry of calcium ions into the cell upon membrane polarization. This gene encodes the alpha-2/delta subunit of the voltage-dependent calcium channel complex. The complex consists of the main channel-forming subunit alpha-1, and auxiliary subunits alpha-2/delta, beta, and gamma. The auxiliary subunits function in the assembly and membrane localization of the complex, and modulate calcium currents and channel activation/inactivation kinetics. The subunit encoded by this gene undergoes post-translational cleavage to yield the extracellular alpha2 peptide and a membrane-anchored delta polypeptide. This subunit is a receptor for the antiepileptic drug, gabapentin. Mutations in this gene are associated with early infantile epileptic encephalopathy. Single nucleotide polymorphisms in this gene are correlated with increased sensitivity to opioid drugs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]
CACNA2D2 Gene-Disease associations (from GenCC):
  • cerebellar atrophy with seizures and variable developmental delay
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012971431).
BP6
Variant 3-50476122-C-T is Benign according to our data. Variant chr3-50476122-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 416536.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000158 (24/152360) while in subpopulation EAS AF = 0.00309 (16/5182). AF 95% confidence interval is 0.00194. There are 0 homozygotes in GnomAd4. There are 13 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006030.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA2D2
NM_006030.4
MANE Select
c.284G>Ap.Arg95His
missense
Exon 2 of 38NP_006021.2Q9NY47-2
CACNA2D2
NM_001174051.3
c.284G>Ap.Arg95His
missense
Exon 2 of 39NP_001167522.1Q9NY47-1
CACNA2D2
NM_001005505.3
c.284G>Ap.Arg95His
missense
Exon 2 of 38NP_001005505.1Q9NY47-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA2D2
ENST00000424201.7
TSL:1 MANE Select
c.284G>Ap.Arg95His
missense
Exon 2 of 38ENSP00000390329.2Q9NY47-2
CACNA2D2
ENST00000423994.6
TSL:5
c.284G>Ap.Arg95His
missense
Exon 2 of 39ENSP00000407393.2C9JVC9
CACNA2D2
ENST00000479441.1
TSL:1
c.284G>Ap.Arg95His
missense
Exon 2 of 39ENSP00000418081.1Q9NY47-1

Frequencies

GnomAD3 genomes
AF:
0.000158
AC:
24
AN:
152242
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00308
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000446
AC:
101
AN:
226484
AF XY:
0.000375
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000607
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00454
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000187
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000180
AC:
260
AN:
1446766
Hom.:
0
Cov.:
30
AF XY:
0.000163
AC XY:
117
AN XY:
718446
show subpopulations
African (AFR)
AF:
0.0000301
AC:
1
AN:
33240
American (AMR)
AF:
0.0000460
AC:
2
AN:
43454
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25840
East Asian (EAS)
AF:
0.00222
AC:
87
AN:
39162
South Asian (SAS)
AF:
0.0000358
AC:
3
AN:
83682
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50650
Middle Eastern (MID)
AF:
0.000695
AC:
4
AN:
5758
European-Non Finnish (NFE)
AF:
0.000136
AC:
150
AN:
1105158
Other (OTH)
AF:
0.000217
AC:
13
AN:
59822
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
12
25
37
50
62
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000158
AC:
24
AN:
152360
Hom.:
0
Cov.:
32
AF XY:
0.000174
AC XY:
13
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.0000240
AC:
1
AN:
41580
American (AMR)
AF:
0.00
AC:
0
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00309
AC:
16
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68042
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000210
Hom.:
0
Bravo
AF:
0.000162
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000181
AC:
22

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
CACNA2D2-related disorder (1)
-
-
1
Developmental and epileptic encephalopathy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.42
CADD
Pathogenic
28
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.026
T
Eigen
Uncertain
0.45
Eigen_PC
Uncertain
0.48
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Uncertain
0.96
D
M_CAP
Benign
0.0099
T
MetaRNN
Benign
0.013
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.5
L
PhyloP100
4.3
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.11
Sift
Benign
0.087
T
Sift4G
Benign
0.11
T
Polyphen
0.99
D
Vest4
0.73
MVP
0.17
MPC
0.64
ClinPred
0.042
T
GERP RS
5.0
Varity_R
0.087
gMVP
0.37
Mutation Taster
=67/33
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149979955; hg19: chr3-50513553; API